News
etectRx Welcomes Scott Kozimor as Vice President of Sales, Driving Innovation in Long-Term Care Technology
2/15/2024
GAINESVILLE, FL. (February 15, 2024) – etectRx, a leading innovator in digital health sensor solutions, proudly announces the appointment of Scott Kozimor as Vice President...
Read More
ALOHA! Adherence: ID-Cap™ Clinical Trial Research Presented at the 2024 Hawaii International Conference on System Sciences (HICSS)
1/24/2024
The ID-Cap™ System embarks on a promising journey in 2024, receiving continued praise from clinical trials. Researchers from Brigham and Women’s Hospital and Ohio State...
Read More
etectRx and The Village at Gainesville Announce Intelligent Incontinence Care Collaboration
11/13/2023
Partnership Marks First Industry Use of Novel Disposable eBrief GAINESVILLE, Fla. (November 13, 2023) – etectRx™, Inc. (etectRx™), a privately held silicon-enabled digital health sensor...
Read More
ID Cap™ System Evolution: Introducing the Wrist-Worn Reader
11/6/2023
The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication...
Read More
Global Growth: University of Cape Town Announces ID-Cap™ System Acceptability Study
10/23/2023
University of Cape Town announces ID-Cap™ System acceptability study in South Africa. Mass General Brigham in collaboration with University of Cape Town is conducting a...
Read More
ID-Cap™ System Powers Historic HIV Digital Pill Study
10/9/2023
etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in...
Read More
Preliminary Analysis of Real-Time Therapy-Based Interventions with ID-Cap™ System Demonstrates Effectiveness of Maintaining Adherence for High-Risk Populations
8/28/2023
NCT03512418- An ongoing study designed to evaluate PrEP adherence data using cognitive behavioral therapy based interventions delivered through the ID-Cap™ System in MSM (men who...
Read More
Leading Digital Pill Solution Surpasses 10,000 Ingestions
3/24/2023
etectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant...
Read More
Remote Therapy Monitoring Billing Guide
3/24/2023
In 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM...
Read More
High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic
3/24/2023
COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from...
Read More
Formative Acceptance of Ingestible Biosensors to Measure Adherence to TB Medications
9/28/2022
Tuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious...
Read More
AARDEX® Group Adds etectRx to their MEMS® Adherence Hardware Ecosystem
4/29/2022
The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the...
Read More